Cargando…
Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial
BACKGROUND: Reflux esophagitis (RE) is a common digestive disorder, and its frequent recurrences cause significant physical pain and are financially burdensome to patients. However, studies on the natural history of treated RE are few. Although proton pump inhibitors (PPIs) as the first-line treatme...
Autores principales: | Sun, Qing-Hua, Wang, Hong-Yan, Sun, Shi-Dong, Zhang, Xin, Zhang, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506578/ https://www.ncbi.nlm.nih.gov/pubmed/31114137 http://dx.doi.org/10.3748/wjg.v25.i17.2110 |
Ejemplares similares
-
Retraction note to: Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial
por: Sun, Qing-Hua, et al.
Publicado: (2023) -
First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease
por: Liang, Chih-Ming, et al.
Publicado: (2017) -
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis
por: Lee, Kang Nyeong, et al.
Publicado: (2022) -
Modified Xiaochaihu Decoction for gastroesophageal reflux disease: A randomized double-simulation controlled trial
por: Li, Zhe, et al.
Publicado: (2021) -
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)
por: Scheiman, James M, et al.
Publicado: (2011)